6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 100mg

3-Bromo-4-chloro-1H-pyrrolo[3,2-c]pyridine, 95.0%, 100mg

4-Bromo-2-methylpyridine hydrochloride, 96%, 5g

4,4'-Dichlorochalcone>98.0%(GC)5g

1-(2-methoxyethyl)-2,3-dihydro-1H-1,3-benzodiazole-2-thione, 97%, 250mg

6-Chloro-3-iodo-4H-chromen-4-one, 95.0%, 1g

5-Fluoro-2,3-dihydrobenzo[b][1,4]dioxine, 96%, 25g

2,5-Bis(trifluoromethyl)aniline, 97.0%, 5g

6-Bromo-3-hydroxypicolinic acid, 95.0%, 250mg

tert-Butyl 4-(6-methyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-1-yl)piperidine-1-carboxylate, 95.0%, 250mg

4-Methoxyphenylacetonitrile>97.0%(GC)25g

tert-butyl 3-[(2,2-diethoxyethyl)amino]propanoate, 95.0%, 10g

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)